⚕️ Biotics AI

Biotics AI built an AI platform to revolutionize fetal abnormality screening, having already secured a $1M investment in a $10B market.

🏃🏻 Rundown

Founder Market Fit

• Robhy Bustami (LinkedIn: Robhy Bustami): Formerly with IBM.

• Salman Khan (LinkedIn: Salman Khan): Formerly at Oracle, shares a college history with Bustami.

• Chaskin Saroff (LinkedIn: Chaskin Saroff): Also from IBM.

The founders identified the problem through their expertise in tech and healthcare. They realized that doctors spent a significant amount of time manually conducting fetal abnormality screenings, prompting them to develop a solution to automate this process.

🤷 Problem

Doctors traditionally spend considerable time manually conducting fetal abnormality screenings. BionicsAI's AI platform automates this process, generating reports and extracting information, saving crucial time for physicians and hospitals.

The AI solution integrates with existing ultrasound machines, enhancing screening quality without requiring expensive hardware investments.

🧐 core business model

• SaaS/Subscription Model: BionicsAI operates on a subscription-based model, providing distinct tiers of service. They boast a robust 78% customer retention rate coupled with an 11% churn rate.

• 4 Growth Factors According to Blitzscaling:

  • Market Size

    • TAM = $10B (Fetal abnormality screening market)

    • SAM = Potential expansion to adjacent fields such as gynecology, urology, and neonatology.

    • SOM = Aiming to capture initial market share within a year with pilot programs and clinical studies in eight institutions.

  • Gross Margins: Not publicly stated, but an 85% margin is anticipated.

  • Distribution: The specifics of distribution are not explicitly outlined, with a focus on 1-1 sales for SaaS Onboarding and potential referrals based on product value.

  • Network Effects: Relies primarily on traditional SaaS word-of-mouth for growth, not heavily dependent on network effects.

• 2 Growth Limiters According to Blitzscaling:

  • Lack of Product-Market Fit (PMF): While the solution is attractive to medical professionals, the direct relevance to enterprise companies might not be immediately clear, especially regarding interaction with a codebase.

  • Operational Scalability: Scaling may yield relatively limited unit economics due to model expenditure. Enhanced customer support and B2B SaaS sales teams will be necessary to align with developer needs.

AI competitive advantage

1. Model Builders: They possess proprietary technology and machine learning models for fetal abnormality screening.

2. Scaling AI: More data improves their AI models' proficiency.

3. Gross Margins: Expected to remain relatively stable.

4. Unit Economics: Improvement but not exponential, requiring sales and software teams for continuous improvement.

why developers love it

Onboard.ai steps in as a real-time AI-powered assistant for developers. It enables seamless interaction with codebases, offering instant access to knowledge and assistance. With just a GitHub sign-in and repository name input, developers can harness AI to streamline their coding tasks.

• Simplification: Onboard.ai simplifies codebase understanding, enabling developers to locate and manipulate code efficiently.

• Data Privacy: All AI models and data stay securely within your cloud, ensuring data privacy and control.

• Empowering Developers: Onboard.ai empowers developers to work smarter, fostering productivity and collaboration.

why you will too!

•  🙏 Future Category King: Onboard.ai is a product-led SaaS. It distinguishes itself by offering a groundbreaking approach to codebase understanding. It empowers developers with real-time assistance and expertise, promoting efficiency and reducing the barriers to effective code management.

• 📈 Market Trend: Onboard.ai has the potential to secure a strong position in the software development AI market, where AI-driven codebase understanding is gaining traction as a fundamental requirement for the industry.

• ⬆️ Traction: Onboard.ai has already made significant strides with a robust client base. Their services are used by top developers around the world, and they've secured $1M million in Seed funding, underscoring investor confidence.

Resources